MedPath
HSA Approval

ZEALARGY TABLET 10mg

SIN17107P

ZEALARGY TABLET 10mg

ZEALARGY TABLET 10mg

October 3, 2024

UNI DRUG HOUSE

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantUNI DRUG HOUSE

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

R06AX28

Manufacturer Information

UNI DRUG HOUSE SDN. BHD.

Cadila Pharmaceuticals Limited

Active Ingredients

Rupatadine Fumarate eq. to Rupatadine 10mg

12.79mg

rupatadine fumarate eq. to rupatadine 10 mg

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ZEALARGY TABLET 10mg - HSA Approval | MedPath